0
Original Research: Cardiovascular Disease |

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant TherapyBleeding Risk Scores in Atrial Fibrillation

Vanessa Roldán, MD, PhD; Francisco Marín, MD, PhD; Hermógenes Fernández, MD; Sergio Manzano-Fernandez, MD, PhD; Pilar Gallego, MD; Mariano Valdés, MD, PhD; Vicente Vicente, MD, PhD; Gregory Y. H. Lip, MD, PhD
Author and Funding Information

From the Hematology and Medical Oncology Unit (Drs Roldán, Fernández, Gallego, and Vicente), Hospital Universitario Morales Meseguer, and the Cardiology Unit (Drs Marín, Manzano-Fernandez, and Valdés), Hospital Universitario Virgen de la Arrixaca, University of Murcia, Murcia, Spain; and the Haemostasis, Thrombosis and Vascular Biology Unit (Dr Lip), University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, England.

Correspondence to: Gregory Y. H. Lip, MD, PhD, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Rd, Birmingham, B18 7QH, England; e-mail: g.y.h.lip@bham.ac.uk


Drs Roldán and Marín are joint first authors of this article.

Funding/Support: This work was partially supported by Sociedad Española de Cardiología, [RD06/0014/039] (RECAVA) from ISCIII, Beca Cajamurcia-FFIS 2010, and PI11/1256 from ISCIII.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2013;143(1):179-184. doi:10.1378/chest.12-0608
Text Size: A A A
Published online

Background:  Despite the clear net clinical benefit of oral anticoagulation for stroke prevention in patients with atrial fibrillation (AF), the occurrence of major bleeding events may be devastating. The HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs/alcohol concomitantly) bleeding risk score was first described in 2010 and is recommended in European and Canadian guidelines to estimate major bleeding risk. In 2011, the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study group described a new bleeding risk scheme for AF, which includes five weighted risk factors: anemia, severe renal disease, age ≥ 75 years, previous hemorrhage, and diagnosed hypertension. We assessed the predictive value of the ATRIA bleeding score in a large cohort of patients with AF receiving anticoagulant therapy, compared with the well-validated HAS-BLED score.

Methods:  We recruited consecutive patients with AF receiving anticoagulant therapy from our outpatient anticoagulation clinic with an INR between 2.0 and 3.0 during the previous 6 months’ clinic visits. During follow-up, major bleeding events were assessed. We assessed both bleeding risk scores as quantitative variables or as dichotomized variables (low-moderate risk vs high risk). Model performance was evaluated by calculating C statistics, and the improvement in predictive accuracy was evaluated by calculating the net reclassification improvement (NRI) and the integrated discrimination improvement (IDI).

Results:  We included 937 patients (49% men; median age, 76 years). Median (interquartile range) follow-up was 952 (785-1,074) days, during which 79 (8%) suffered a major bleeding event (annual rate, 3.2%). The HAS-BLED score had a model performance (based on C statistics) similar to that of the ATRIA score as a quantitative variable (C statistic, 0.71 vs 0.68; P = .356) but was superior to the ATRIA score when analyzed as a dichotomized variable (C statistic, 0.68 vs 0.59; P = .035). Both NRI and IDI analyses demonstrated that the HAS-BLED score more accurately predicted major bleeding episodes than did the ATRIA risk score, as reflected in the percentage of events reclassified correctly.

Conclusion:  The HAS-BLED score shows significantly better prediction accuracy than the weighted (and more complex) ATRIA score. Our findings reinforce the incremental usefulness of the simple HAS-BLED score over other published bleeding risk scores in patients with AF receiving anticoagulant therapy.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543